Birnbaum, D.J.; Picard, M.; Da Costa, Q.; Delayre, T.; Finetti, P.; Cabaud, O.; Agavnian, E.; De Rauglaudre, B.; Denicolaï, E.; Bertucci, F.;
et al. PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers 2023, 15, 447.
https://doi.org/10.3390/cancers15020447
AMA Style
Birnbaum DJ, Picard M, Da Costa Q, Delayre T, Finetti P, Cabaud O, Agavnian E, De Rauglaudre B, Denicolaï E, Bertucci F,
et al. PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers. 2023; 15(2):447.
https://doi.org/10.3390/cancers15020447
Chicago/Turabian Style
Birnbaum, David Jeremie, Maelle Picard, Quentin Da Costa, Thomas Delayre, Pascal Finetti, Olivier Cabaud, Emilie Agavnian, Bernadette De Rauglaudre, Emilie Denicolaï, François Bertucci,
and et al. 2023. "PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma" Cancers 15, no. 2: 447.
https://doi.org/10.3390/cancers15020447
APA Style
Birnbaum, D. J., Picard, M., Da Costa, Q., Delayre, T., Finetti, P., Cabaud, O., Agavnian, E., De Rauglaudre, B., Denicolaï, E., Bertucci, F., & Mamessier, E.
(2023). PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers, 15(2), 447.
https://doi.org/10.3390/cancers15020447